Furthermore, Li et al. reported a decline in both GFAP-positive areas and Aβ levels following ginseng compound treatment, reinforcing the anti-inflammatory and neuroprotective properties of ginseng derivatives in AD models18. This evidence concerns the gene GFAP and Alzheimer disease.